Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection

Annals of Surgery

Volumn 254, Issue 2, 2011, Pages 302-310

  Ehehalt, Florian ^a   Rümmele, Petra ^b   Kersting, Stephan ^a   Lang Schwarz, Corinna ^b   Rückert, Felix ^a   Hartmann, Arndt ^c   Dietmaier, Wolfgang ^b   Terracciano, Luigi ^d   Aust, Daniela E ^a   Jahnke, Beatrix ^a   Saeger, Hans Detlev ^a   Pilarsky, Christian ^a   Grützmann, Robert ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; MUCIN 1; TRANSCRIPTION FACTOR CDX2;

AMPULLARY CANCER; ARTICLE; BIOINFORMATICS; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE MARKER; EARLY DIAGNOSIS; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VATER PAPILLA;

ADENOCARCINOMA; ADULT; AGED; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; IMMUNOENZYME TECHNIQUES; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; SURVIVAL RATE; UP-REGULATION;

EID: 79961029833     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31821994a8     Document Type: Article

References (37)

1. Bouvet M, Gamagami RA, Gilpin EA, et al. Factors influencing survival after resection for periampullary neoplasms. Am J Surg. 2000;180(1):13-17.
2. Chang MC, Chang YT, Tien YW, et al. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization. Oncol Rep. 2005;14(4):867-872.
3. Esposito I, Friess H, Buchler MW. Carcinogenesis of cancer of the papilla and ampulla: pathophysiological facts and molecular biological mechanisms. Langenbecks Arch Surg. 2001;386(3):163-171. (Pubitemid 32422537)
4. Friess H, Guo XZ, Tempia-Caliera AA, et al. Differential expression of metastasis-associated genes in papilla of Vater and pancreatic cancer correlates with disease stage. J Clin Oncol. 2001;19(9):2422-2432. (Pubitemid 32391213)
5. Ruemmele P, Dietmaier W, Terracciano L, et al. Histopathologic features and microsatellite instability of cancers of the papilla of Vater and their precursor lesions. Am J Surg Pathol. 2009;33(5):691-704.
6. Stolte M, Pscherer C. Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol. 1996;31(4):376-382. (Pubitemid 26117759)
7. Chung CH, Wilentz RE, Polak MM, et al. Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol. 1996;49(6):460-464. (Pubitemid 26226534)
8. Howe JR, Klimstra DS, Cordon-Cardo C, et al. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res. 1997;3(1):129-133. (Pubitemid 27079455)
9. Kaiser A, Jurowich C, Schonekas H, et al. The adenoma-carcinoma sequence applies to epithelial tumours of the papilla of Vater. Z Gastroenterol. 2002;40(11):913-920. (Pubitemid 35408226)
10. Park S, Kim SW, Kim SH, et al. Loss of heterozygosity in ampulla of Vater neoplasms during adenoma-carcinoma sequence. Anticancer Res. 2003;23(3 C):2955-2959. (Pubitemid 36969843)
11. Fischer HP, Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg. 2004;11(5):301-309. (Pubitemid 39485631)
12. Kimura W, Futakawa N, Yamagata S, et al. Different clinicopathologicfindings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res. 1994;85(2):161-166. (Pubitemid 24074541)
13. Westgaard A, Tafjord S, Farstad IN, et al. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer. 2008;8:170.
14. Heinrich S, Clavien PA. Ampullary cancer. Curr Opin Gastroenterol. 2010;26(3):280-285.
15. Hansel DE, Maitra A, Lin JW, et al. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. J Clin Oncol. 2005;23(9):1811-1818. (Pubitemid 46211359)
16. Goldstein NS, Bassi D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001;115(5):695-702. (Pubitemid 33051536)
17. Sessa F, Furlan D, Zampatti C, et al. Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch. 2007;451(3):649-657. (Pubitemid 47340981)
18. Chu PG, Schwarz RE, Lau SK, et al. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Am J Surg Pathol. 2005;29(3):359-367. (Pubitemid 40321972)
19. Zhou H, Schaefer N, Wolff M, et al. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am J Surg Pathol. 2004;28(7):875-882. (Pubitemid 38856842)
20. Howe JR, Klimstra DS, Moccia RD, et al. Factors predictive of survival in ampullary carcinoma. Ann Surg. 1998;228(1):87-94. (Pubitemid 30190320)
21. Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg. 1997;225(5):590-599; discussion 599-600.
22. Grutzmann R, Pilarsky C, Ammerpohl O, et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia. 2004;6(5):611-622. (Pubitemid 39411099)
23. Li C. Automating dChip: toward reproducible sharing of microarray data analysis. BMC Bioinformat. 2008;9:231.
24. Albores-Saavedra J, Henson DE, Klimstra DS. Tumours of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. In: Atlas of Tumor Pathology, Vol. 3rd series. Washington, DC: Armed Forces Institute of Pathology; 2000:171-174.
25. Bubendorf L, Nocito A, Moch H, et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol. 2001;195(1):72-79.
26. Baumhoer D, Zlobec I, Tornillo L, et al. Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater. Virchows Arch. 2008;453(6):579-588.
27. Simon R, Sauter G. Tissue microarray (TMA) applications: implications for molecular medicine. Expert Rev Mol Med. 2003;5(26):1-12.
28. Woenckhaus M, Merk J, Stoehr R, et al. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol. 2008;39(1):126-136. (Pubitemid 350216169)
29. Lugli A, Tzankov A, Zlobec I, et al. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Mod Pathol. 2008;21(11):1403-1412.
30. O'Connell JB, Maggard MA, Manunga J, Jr., et al. Survival after resection of ampullary carcinoma: a national population-based study. Ann Surg Oncol. 2008;15(7):1820-1827.
31. de PaivaHaddad LB, Patzina RA, Penteado S, et al. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. J Gastrointest Surg. 14(4):719-728.
32. Yamagata K. Regulation of pancreatic beta-cell function by the HNF transcription network: lessons from maturity-onset diabetes of the young (MODY). Endocr J. 2003;50(5):491-499. (Pubitemid 37442824)
33. Cattin AL, Le Beyec J, Barreau F, et al. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol. 2009;29(23):6294-6308.
34. Babeu JP, Darsigny M, Lussier CR, et al. Hepatocyte nuclear factor 4alpha contributes to an intestinal epithelial phenotype in vitro and plays a partial role in mouse intestinal epithelium differentiation. Am J Physiol Gastrointest Liver Physiol. 2009;297(1):G124-G134.
35. Benahmed F, Gross I, Gaunt SJ, et al. Multiple regulatory regions control the complex expression pattern of the mouse Cdx2 homeobox gene. Gastroenterology. 2008;135(4):1238-1247, 1247 e1-3.
36. Boyd M, Bressendorff S, Moller J, et al. Mapping of HNF4alpha target genes in intestinal epithelial cells. BMC Gastroenterol. 2009;9:68.
37. Takegoshi S, Jiang S, Ohashi R, et al. Protein expression of nuclear receptors in human and murine tissues. Pathol Int. 2009;59(2):61-72.